ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.07%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,649.87
0.00%
Brent Oil
71.98
0.00%
Bitcoin
97,018.75
0.60%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cymabay Therapeutics Inc (CBAY)

  7. Cymabay Therapeutics Inc (CBAY) News

Cymabay Therapeutics (CBAY)

Cymabay Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBAY
DateTimeSourceHeadlineSymbolCompany
22/03/202413:18Business WireGilead Sciences Announces Completion of Acquisition of CymaBayNASDAQ:CBAYCymabay Therapeutics Inc
11/03/202413:14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
07/03/202421:35Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
28/02/202422:01Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
23/02/202411:25Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CBAYCymabay Therapeutics Inc
16/02/202422:14Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
15/02/202421:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
14/02/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
14/02/202421:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
14/02/202417:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CBAYCymabay Therapeutics Inc
14/02/202414:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
13/02/202421:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
12/02/202422:29Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202418:43PR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202413:45Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202413:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBAYCymabay Therapeutics Inc
06/02/202422:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/02/202422:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
30/01/202423:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
29/01/202422:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
26/01/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CBAY

Your Recent History

BIT
F38656
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Level 2 Lite

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £2132.64 only 1066.32